Molecular Profile | Unknown unknown |
Therapy | PD-0325901 |
Indication/Tumor Type | colorectal cancer |
Response Type | not applicable |
Create By | rliu |
Update By | spatt |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | Unknown unknown | colorectal cancer | not applicable | PD-0325901 | Phase I | Actionable | In a Phase I study, PD-325901 demonstrated efficacy but toxicity at current dose was unacceptable (PMID: 21516509). | 21516509 |
---|
PubMed Id | Reference Title | Details |
---|---|---|
(21516509) | Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer. | Full reference... |